Canaccord Genuity Maintains Buy on Core Scientific, Raises Price Target to $36
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
Canaccord Genuity analyst Joseph Vafi maintains Core Scientific (NASDAQ:CORZ) with a Buy and raises the price target from $30 to $36.
Canaccord Genuity analyst Joseph Vafi maintains Core Scientific (NASDAQ:CORZ) with a Buy and raises the price target from $30 to $36.